Shelly R. Selvaraj - 08 Sep 2022 Form 4 Insider Report for DEXCOM INC (DXCM)

Role: SVP Chief Information Officer
Signature: By: Jereme Sylvain For: Shelly R Selvaraj
Issuer symbol: DXCM
Transactions as of: 08 Sep 2022
Net transactions value: +$4.05
Form type: 4
Filing time: 12 Sep 2022, 17:56:41 UTC
Previous filing: 14 Mar 2022
Next filing: 10 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DXCM	Common Stock	Award	$4.05	+4,051	+8.8%	$0.001000^*	49,942	08 Sep 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This RSU Award was granted pursuant to the Amended and Restated 2015 Equity Incentive Plan, in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F2	Adjusted to reflect Dexcom's 4-for-1 stock split, effective on June 10, 2022. Included in this number are 31,107 unvested restricted stock units, 4,051 of which were granted on September 8, 2022 and shall all vest on September 8, 2023, 11,556 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 8,192 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 7,308 of which were granted on March 8, 2020 and shall vest through March 8, 2023.

Content

This RSU Award was granted pursuant to the Amended and Restated 2015 Equity Incentive Plan, in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.

Adjusted to reflect Dexcom's 4-for-1 stock split, effective on June 10, 2022. Included in this number are 31,107 unvested restricted stock units, 4,051 of which were granted on September 8, 2022 and shall all vest on September 8, 2023, 11,556 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 8,192 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 7,308 of which were granted on March 8, 2020 and shall vest through March 8, 2023.